Christopher Bravery

Consulting Regulatory Scientist at Consulting on Advanced Biologicals, UK

Speaker

Christopher founded Consulting on Advanced Biologicals Ltd at the end of 2009 in order to support those developing ATMP and other novel biological medicines. Advbiols focuses on the application of regulatory science to preclinical and quality, along with European regulatory strategy. In addition to providing consulting services, Christopher also runs workshops on various topics. Christopher has a PhD in xenotransplantation immunology and spent 8 years in biotech (Imutran Ltd, A Novartis Pharma AG Co. and Intercytex) before joining the MHRA as a quality (CMC) assessor (biologicals and biotechnology unit). During this time Christopher was involved with National implementation of the new Advanced Therapies Regulation and also involved through his participation in the CHMP’s cell products working party (CPWP) in implementation at the EMA level including drafting guidelines.